InVivo Therapeutics Corp P / E
Was ist das P / E von InVivo Therapeutics Corp?
P / E von InVivo Therapeutics Holdings Corp ist 0.00
Was ist die Definition von P / E?
Das Terminkurs-Gewinn-Verhältnis ist das Verhältnis des Aktienkurses eines Unternehmens zum geschätzten Gewinn des Unternehmens je Aktie für die nächsten zwölf Monate.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P / E von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu InVivo Therapeutics Corp
Was macht InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Unternehmen mit p / e ähnlich InVivo Therapeutics Corp
- Richland Resources International hat P / E von N/A
- Safeplus International hat P / E von N/A
- China Yanyuan Yuhui Natl Ed Grp hat P / E von N/A
- Acusphere hat P / E von N/A
- American Oriental Bioengineering hat P / E von N/A
- Gourmet Provisions International hat P / E von N/A
- InVivo Therapeutics Corp hat P / E von 0.00
- SEL Manufacturing hat P / E von 0.00
- China Zhong Qi Hldgs hat P / E von 0.00
- MedSmart hat P / E von 0.00
- Panbela Therapeutics hat P / E von 0.00
- Epic hat P / E von 0.00
- 2574 hat P / E von 0.00